pH-Sensitive Polymer Sequesters Bile Acid Micelles
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacotherapies for obesity lack long-term efficacy, safety, and patient compliance, and there is no uniformly effective treatment for reducing excess weight and associated metabolic syndrome conditions.
Innovation Solution
A polymer-based fat and bile acid sequestrant composition, comprising a pH-sensitive monomer and a positively-charged monomer, that binds lipid/bile acid micelles in the small intestine, inducing flocculation and preventing absorption, thereby promoting weight loss and reducing cholesterol and lipid absorption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional pharmacotherapies are used to treat obesity, then weight loss can be achieved, but long-term efficacy and patient compliance are insufficient
Solution Approach 1:
The patent employs pH-sensitive polymers that undergo conformational changes in response to pH variations in the gastrointestinal tract. The polymer transitions from a soluble state in the acidic stomach environment to an insoluble flocculated state in the neutral/alkaline intestinal environment, enabling controlled release and sustained action that improves long-term efficacy and compliance
Solution Approach 2:
The invention uses copolymer compositions combining pH-sensitive monomers (such as vinylpyridine or diethylaminoethyl methacrylate) with positively-charged monomers (such as trimethylammonium chloride). This composite polymer structure integrates both pH-responsive conformational changes and electrostatic binding capabilities to enhance micelle sequestration efficiency and sustained weight loss management
2Duration of action of moving object
If existing obesity treatments are administered, then weight reduction can occur, but safety profiles and tolerable side effects are limited
Solution Approach 1:
The pH-sensitive polymer performs its sequestration function autonomously through pH-induced conformational changes and electrostatic interactions with micelles. The polymer self-regulates its binding and release based on the local pH environment, eliminating the need for external control mechanisms and reducing the risk of adverse effects associated with actively regulated drug delivery systems
Solution Approach 2:
The polymer's solubility and binding properties are dynamically adjusted in response to pH changes along the gastrointestinal tract. This passive pH-responsive mechanism ensures the polymer remains soluble in the stomach for absorption but flocculates in the intestine to bind micelles, providing a safe profile with minimal side effects while maintaining long-term efficacy
3Productivity
If polymer-based sequestrants are used to bind micelles, then weight loss and cholesterol reduction are achieved, but manufacturing precision and composition control are required
Solution Approach 1:
The patent employs copolymer compositions where specific monomer units are positioned to provide different functions: pH-sensitive monomers (such as vinylpyridine) provide conformational response to pH changes, while positively-charged monomers (such as trimethylammonium chloride) provide electrostatic binding to negatively-charged micelles. This local differentiation of functional groups within the polymer chain enables precise control over sequestration efficiency and micelle binding characteristics
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer composition achieves high micelle sequestration efficiency, leading to effective weight loss, reduced cholesterol levels, and improved treatment compliance with fewer side effects, addressing the limitations of existing obesity treatments.
Implementation Method 1
the pH-sensitive monomer of the present polymer compositions can transition from a soluble phase to an insoluble phase upon a particular pH change
Implementation Method 2
a copolymer of a pH-sensitive monomer and of at least one positively-charged monomer... capable of binding a lipid/bile acid-containing micelle
Implementation Method 3
Upon binding the micelle, the polymer compositions of the present disclosure are capable of inducing flocculation of the polymer:micelle complex
Data Source
AI summary
A polymer composition for sequestering lipid-bile acid micelles in the gastrointestinal (GI) tract is provided. The polymer composition comprises a copolymer of a pH-sensitive monomer and one or more of positively-charged monomers. The polymer composition is able to bind micelles under various physiological conditions in the GI tract and possesses the ability to flocculate the bound micelle upon exposure to a particular pH. The flocculation of the polymer:micelle complex prevents absorption of the micelle thereby causing the polymer:micelle complex to be eliminated with the fecal matter. Thus, the polymer composition described herein may be effective in reducing cholesterol, bile acid, and/or triglyceride levels and promote weight loss.